Business
ZEO ScientifiX, Inc. (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on regenerative biologics, announced on September 15, 2026 its planned expansion into Georgia and United States — Tennessee. The move follows the recent enactment of state…
Impact: United States — Tennessee enacted House Bill 2246 on May 19, 2026, authorizing qualifying stem cell and regenerative medicine therapies and expressly including certain exosome-based products, opening a market for ZEO ScientifiX.
Sep 15, 2026 · 6 articles